BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 24, Issue 6, Pages 881-888
Publisher
Springer Nature
Online
2015-09-09
DOI
10.1038/ejhg.2015.196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- (2015) Fergus J. Couch et al. JOURNAL OF CLINICAL ONCOLOGY
- MRI breast screening in high-risk women: cancer detection and survival analysis
- (2014) Evans D. Gareth et al. BREAST CANCER RESEARCH AND TREATMENT
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
- (2014) H. Song et al. HUMAN MOLECULAR GENETICS
- Easy-to-Use Decision Aids for Improved Cancer Family History Collection and Use Among Oncology Practices
- (2014) Aisha S. Sie et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality of Cancer Family History and Referral for Genetic Counseling and Testing Among Oncology Practices: A Pilot Test of Quality Measures As Part of the American Society of Clinical Oncology Quality Oncology Practice Initiative
- (2014) Marie E. Wood et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
- (2013) J.-m. Lee et al. ANNALS OF ONCOLOGY
- Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
- (2013) P. Pujol et al. BREAST CANCER RESEARCH AND TREATMENT
- Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral
- (2013) Sarah L. Ingham et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
- (2013) Richard M Brohet et al. JOURNAL OF MEDICAL GENETICS
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months
- (2013) Lesley Stafford et al. PSYCHO-ONCOLOGY
- Cognitive and Psychological Impact of BRCA Genetic Counseling in Before and After Definitive Surgery Breast Cancer Patients
- (2012) Juliette Christie et al. ANNALS OF SURGICAL ONCOLOGY
- Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined
- (2012) E. A. M. Heijnsdijk et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer
- (2012) Pawel Gaj et al. Familial Cancer
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk
- (2012) Amanda B Spurdle et al. JOURNAL OF MEDICAL GENETICS
- Personality, physical activity, and symptoms of anxiety and depression: the HUNT study
- (2012) Audun Brunes et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Health-related quality of life among women with breast cancer – a population-based study
- (2011) Marie Høyer et al. ACTA ONCOLOGICA
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
- (2009) Allison W Kurian CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
- (2009) D G R Evans et al. JOURNAL OF MEDICAL GENETICS
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
- (2009) T. R. Rebbeck et al. JNCI-Journal of the National Cancer Institute
- Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
- (2008) K A Metcalfe et al. BRITISH JOURNAL OF CANCER
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
- (2008) Sharon E. Plon et al. HUMAN MUTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started